Fiber Intake in an End Stage Renal Disease (ESRD) Population Followed Over 2 Years

Sponsor
Northwell Health (Other)
Overall Status
Completed
CT.gov ID
NCT00874380
Collaborator
Staten Island University Hospital (Other)
70
1
32
2.2

Study Details

Study Description

Brief Summary

Our research involves the detailed description of the content of the diet of x dialysis patients.

For our purpose we used a newly developed "food frequency questionnaire". This is the first validated questionnaire specific for dialysis patients and we were the first to use it.

Our special focus was the fiber content in the diet of our patient. Our thesis that they are way below the recommended guidelines for fiber intake was verified. Our follow will evaluate the effect of such at diet, mosTLy cardiovascular.

Condition or Disease Intervention/Treatment Phase
  • Other: Increasing total fiber intake in patient's diet

Study Design

Study Type:
Observational
Actual Enrollment :
70 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Fiber Content of Hemodialysis Patients' Diet and it's Cardiovascular Implications.
Study Start Date :
Oct 1, 2008
Actual Primary Completion Date :
Jun 1, 2011
Actual Study Completion Date :
Jun 1, 2011

Arms and Interventions

Arm Intervention/Treatment
1

First describe the diet of a cohort of dialysis patients with focus on fiber content.

Other: Increasing total fiber intake in patient's diet
Second counsel patients biweekly about their compliance with a high fiber diet, target being 25 to 30 gm of fiber a day.Follow them for a period of 2 years and assess if their is any significant decrease in their cardiovascular events and profile, in addition to assessing the effect of high fiber on kalemia.

Outcome Measures

Primary Outcome Measures

  1. cardiovascular event [2 years]

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients with end stage renal disease on hemodialysis

  • Patients who are able to give informed consent

Exclusion Criteria:
  • Pregnant women.

  • Cognitively impaired patients

  • PEG feeding

Contacts and Locations

Locations

Site City State Country Postal Code
1 Staten Island University Hospital Staten Island New York United States 10305

Sponsors and Collaborators

  • Northwell Health
  • Staten Island University Hospital

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Suzanne El-Sayegh, Nephrology Attending, Assoc. Chair of Medicine, Northwell Health
ClinicalTrials.gov Identifier:
NCT00874380
Other Study ID Numbers:
  • 08-036
First Posted:
Apr 2, 2009
Last Update Posted:
May 15, 2013
Last Verified:
May 1, 2013
Keywords provided by Suzanne El-Sayegh, Nephrology Attending, Assoc. Chair of Medicine, Northwell Health

Study Results

No Results Posted as of May 15, 2013